Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Erbamont/Unigene calcitonin production

Executive Summary

Two firms announced development of a procedure that enables production of larger quantities of the hormone. They explained that a strain of bacteria able to synthesize high levels of an inactive precursor of calcitonin was genetically engineered. "Specific conversion of the C-terminus of this substrate to the active amidated product was then accomplished" using Unigene's single-step amidation process, the companies reported. The naturally occurring peptide stimulates the incorporation of calcium into bones.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS008340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel